journal article·2024-07-24

Programming of in Situ Tumor Vaccines via Supramolecular Nanodrug/Hydrogel Composite and Deformable Nanoadjuvant for Cancer Immunotherapy

Shuaiqi Shao, Ziyang Cao, Zekai Xiao, Boya Yu, Lingwei Hu, Xiao-Jiao Du, Xianzhu Yang

Nano Letters· Volume 24· Issue 29
Publisher page

Abstract

The development of in situ tumor vaccines offers promising prospects for cancer treatment. Nonetheless, the generation of plenary autologous antigens in vivo and their codelivery to DC cells along with adjuvants remains a significant challenge. Herein, we developed an in situ tumor vaccine using a supramolecular nanoparticle/hydrogel composite (ANP MTO /ALCD) and a deformable nanoadjuvant (PPE R848 ). The ANP MTO /ALCD composite consisted of β-cyclodextrin-decorated alginate (Alg- g -CD) and MTO-encapsulated adamantane-decorated nanoparticles (ANP MTO ) through supramolecular interaction, facilitating the long-term and sustained production of plenary autologous antigens, particularly under a 660 nm laser. Simultaneously, the produced autologous antigens were effectively captured by nanoadjuvant PPE R848 and subsequently transported to lymph nodes and DC cells, benefiting from its optimized size and deformability. This in situ tumor vaccine can trigger a robust antitumor immune response and demonstrate significant therapeutic efficacy in inhibiting tumor growth, suppressing tumor metastasis, and preventing postoperative recurrence, offering a straightforward approach to programming in situ tumor vaccines.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong 511442, People’s Republic of China

Center for Medical Research on Innovation and Translation, Institute of Clinical Medicine, Guangzhou First People’s Hospital, the Second Affiliated Hospital, South China University of Technology, Guangzhou, Guangdong 510180, People’s Republic of China

School of Medicine, South China University of Technology, Guangzhou 510006, People’s Republic of China

National Engineering Research Center for Tissue Restoration and Reconstruction, and Guangdong Province Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou, Guangdong 510006, People’s Republic of China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · Scientific and Technological Planning Project of Guangzhou City

References (31)

Show source-provided references
1. 10.1126/science.aar406010.1126/science.aar4060 ↗
2. 10.1158/1078-0432.CCR-11-011610.1158/1078-0432.CCR-11-0116 ↗
3. 10.1038/s41467-019-10948-w10.1038/s41467-019-10948-w ↗
4. 10.1002/ijc.3426710.1002/ijc.34267 ↗
5. 10.1053/j.seminoncol.2018.07.00310.1053/j.seminoncol.2018.07.003 ↗
6. 10.1016/j.jtho.2023.07.00210.1016/j.jtho.2023.07.002 ↗
7. 10.1200/jco.2015.33.15_suppl.lba10010.1200/jco.2015.33.15_suppl.lba100 ↗
8. 10.1016/j.cell.2021.09.02010.1016/j.cell.2021.09.020 ↗
9. 10.1186/s13046-022-02327-z10.1186/s13046-022-02327-z ↗
10. 10.1126/science.aar711210.1126/science.aar7112 ↗
11. 10.3389/fimmu.2020.0018810.3389/fimmu.2020.00188 ↗
12. 10.1038/ncponc085410.1038/ncponc0854 ↗
13. 10.1002/adma.20230984310.1002/adma.202309843 ↗
14. 10.1021/acsnano.3c0563510.1021/acsnano.3c05635 ↗
15. 10.1016/S1470-2045(22)00372-210.1016/S1470-2045(22)00372-2 ↗
16. 10.1038/s41392-023-01674-310.1038/s41392-023-01674-3 ↗
17. 10.1021/acsnano.3c0503410.1021/acsnano.3c05034 ↗
18. 10.1038/s41467-022-33831-710.1038/s41467-022-33831-7 ↗
19. 10.1002/adma.20200729310.1002/adma.202007293 ↗
20. 10.1126/sciadv.aaw607110.1126/sciadv.aaw6071 ↗
21. 10.1146/annurev-immunol-020711-07495010.1146/annurev-immunol-020711-074950 ↗
22. 10.1021/ar500055s10.1021/ar500055s ↗
23. 10.1002/adma.20200729310.1002/adma.202007293 ↗
24. 10.1002/adfm.20230223110.1002/adfm.202302231 ↗
25. 10.1038/ncomms1319310.1038/ncomms13193 ↗
26. 10.1021/acsnano.2c0656010.1021/acsnano.2c06560 ↗
27. 10.1002/adfm.20210365510.1002/adfm.202103655 ↗
28. 10.1002/adfm.20160319510.1002/adfm.201603195 ↗
29. 10.1021/am506872310.1021/am5068723 ↗
30. 10.1016/j.biomaterials.2014.04.00910.1016/j.biomaterials.2014.04.009 ↗
31. 10.1021/acsami.0c1234110.1021/acsami.0c12341 ↗